BAY 1021189
21683 "VELOCITY"
Phase 2 small_molecule active
Quick answer
BAY 1021189 for Chronic heart failure with reduced ejection fraction is a Phase 2 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Chronic heart failure with reduced ejection fraction
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active